HUMORAL AND CELLULAR IMMUNOGENICITY OF THE THIRD DOSE OF MRNA VACCINES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ON BELIMUMAB

被引：0
|
作者：
Luca, Q. [1 ]
De Marchi, G. [1 ]
Domenis, R. [2 ]
Cabas, N. [1 ]
Guella, S. [1 ]
Paradiso, A. [2 ]
Fabro, C. [1 ]
Beltrami, A. P. [2 ]
De Vita, S. [1 ]
Curcio, F. [2 ]
机构：
[1] Acad Hosp Santa Maria della Misericordia, Div Rheumatol, Dept Med DAME, I-33100 Udine, Italy
[2] Acad Hosp Santa Maria della Misericordia, Inst Clin Pathol, ASUFC, Dept Med DAME, I-33100 Udine, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Systemic lupus erythematosus; COVID; Diagnostic tests;
D O I：
10.1136/annrheumdis-2023-eular.5645
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0548
引用
收藏
页码：539 / 540
页数：2
相关论文
共 50 条
  • [41] Belimumab for systemic lupus erythematosus: breaking through?
    Dall'Era, Maria
    Wofsy, David
    NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (03) : 124 - 125
  • [42] Belimumab is not associated with COVID-19 mRNA vaccination failure in systemic lupus erythematosus
    Boedecker-Lips, Simone Cosima
    Classen, Paul
    Kraus, Daniel
    Weinmann-Menke, Julia
    RHEUMATOLOGY, 2023, 62 (03) : E34 - E35
  • [43] Prediction of Belimumab Pharmacokinetics in Chinese Pediatric Patients with Systemic Lupus Erythematosus
    Xuan Zhou
    Tsung-I Lee
    Min Zhu
    Peiming Ma
    Drugs in R&D, 2021, 21 : 407 - 417
  • [44] Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus
    Trefond, Ludovic
    Zahr, Noel
    Lhote, Raphael
    Pha, Micheline
    Hie, Miguel
    Miyara, Makoto
    Papo, Matthias
    Moyon, Quentin
    Hausfater, Pierre
    Chasset, Francois
    Haroche, Julien
    Cohen-Aubart, Fleur
    Mathian, Alexis
    Amoura, Zahir
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (04) : 541 - 543
  • [45] Different pregnancy outcomes in patients with systemic lupus erythematosus treated with belimumab
    Lai, Yupeng
    Li, Bin
    Huang, Jiaming
    Du, Jingning
    Yue, Mengli
    Shen, Xin
    Liu, Xingjiao
    Huang, Lingfeng
    Lin, Jiehua
    Yang, Aicheng
    Wang, Meiying
    LUPUS, 2023, 32 (01) : 149 - 154
  • [46] EFFECTIVENESS OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS OF A MULTICENTER SPANISH COHORT
    Altabas Gonzalez, I.
    Pego-Reigosa, J. M.
    Mourino Rodriguez, C.
    Jimenez, N.
    Hernandez-Martin, A.
    Casafont-Sole, I.
    Font, J.
    De La Rubia Navarro, M.
    Roman Ivorra, J. A.
    Galindo, M.
    Salman Monte, T. C.
    Vidal Montal, P.
    Narvaez, J.
    Garcia Villanueva, M. J.
    Piqueras Garcia, M. M.
    Fernandez Cid, C. Marras
    Martinez-Barrio, J.
    Sanchez Lucas, M.
    Penzo, E.
    Cortes-Hernandez, J.
    Alvarez Rodriguez, B.
    Vasques Rocha, M.
    Tomero Muriel, E.
    Menor-Almagro, R.
    Gandia Martinez, M.
    Frade-Sosa, B.
    Gomez-Puerta, J. A.
    Trapero, C.
    Ramos Giraldez, C.
    Moriano, C.
    Diez Alvarez, E.
    Munoz Jimenez, A.
    Rua-Figueroa, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 901 - 902
  • [47] Prediction of Belimumab Pharmacokinetics in Chinese Pediatric Patients with Systemic Lupus Erythematosus
    Zhou, Xuan
    Lee, Tsung-, I
    Zhu, Min
    Ma, Peiming
    DRUGS IN R&D, 2021, 21 (04) : 407 - 417
  • [48] B Cell Signature Profiling in Systemic Lupus Erythematosus Patients on Belimumab
    Ngo, Michelle T.
    Benitez, Abigail
    Payne, Kimberly J.
    De Vera, Michael
    Milford, Terry Ann
    Torralba, Karina Marianne D.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [49] EARLY CLINICAL EXPERIENCES WITH BELIMUMAB IN POLISH PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Majdan, M.
    Kucharz, E. J.
    Jeka, S.
    Sierakowski, S.
    Leszczynski, P.
    Tlustochowicz, W.
    Olesinska, M.
    Gluszko, P.
    Krezelok, M.
    Suszek, D.
    Kopec-Medrek, M.
    Kolossa, K.
    Domyslawska, I.
    Pawlak-Bus, K.
    Kur-Zalewska, J.
    Felis-Giemza, A.
    Zielinska, A.
    Bruzewicz, S.
    Skoczylas, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 970 - 970
  • [50] EFFECT OF BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH MINIMAL OR NO STEROID
    Lee, Y. J.
    Ahn, S. M.
    Hong, S.
    Oh, J. S.
    Lee, C. K.
    Yoo, B.
    Kim, Y. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1474 - 1474
12345